05/01/2026
A rare incidence of small cell transformation of a previously operated right lower lobe stage 2 nsclc on osimertinib for 3 years. This time the recurrence was at the middle lobe.
The prognosis is poor, but after tumor board discussion, decision was made for surgery since it is a localised disease.
The surgery was extremely challenging.
https://youtu.be/-lonHFNBuP4?si=e_USyzULv67EYDBB
A rare incidence of small cell transformation of a previously operated right lower lobe stage 2 nsclc on osimertinib for 3 years. This time the recurrence w...